Introduction — This topic includes links to society and government-sponsored guidelines from selected countries and regions around the world. We will update these links periodically; newer versions of some guidelines may be available on each society's website. Some societies may require users to log in to access their guidelines.
The recommendations in the following guidelines may vary from those that appear in UpToDate topic reviews. Readers who are looking for UpToDate topic reviews should use the UpToDate search box to find the relevant content.
International
●International Federation of Gynecology and Obstetrics (FIGO): Cancer report on the cancer of the corpus uteri (2018)
●FIGO: Cancer report on the role of imaging in the routine management of endometrial cancer (2018)
●FIGO: Cancer report on uterine sarcomas (2018)
Canada
●Cancer Care Ontario (CCO): Systemic therapy for advanced or recurrent endometrial cancer and advanced or recurrent uterine papillary serous carcinoma (2019)
●Society of Gynecologic Oncology of Canada (GOC)-Society of Obstetricians and Gynaecologists of Canada (SOGC): Joint clinical practice guideline on classification and management of endometrial hyperplasia (2019)
●SOGC: Clinical practice guideline on asymptomatic endometrial thickening (2010, reaffirmed 2018)
●SOGC: Clinical practice guideline on epidemiology and investigations for suspected endometrial cancer (2013, reaffirmed 2018)
●CCO: Follow-up after primary therapy for endometrial cancer (2017)
●CCO: Screening for Lynch syndrome by immunohistochemistry, BRAF mutations analysis, and MLH1 promoter methylation analysis for patients in Ontario with colorectal or endometrial cancers (2015)
●British Columbia (BC) Guidelines: Guidelines on genital tract cancers in females − Endometrial cancer (2014)
United States
●American College of Obstetricians and Gynecologists (ACOG): Committee opinion on tamoxifen and uterine cancer (2014, reaffirmed 2020)
●ACOG and SGO: Committee opinion – Endometrial intraepithelial neoplasia (2015, reaffirmed 2020)
●American College of Radiology (ACR): ACR Appropriateness Criteria on pretreatment evaluation and follow-up of endometrial cancer (2020)
●Society of Gynecologic Oncology (SGO): Clinical practice statement on hormone therapy (HT) in women with gynecologic cancers and in women at high risk for developing a gynecologic cancer (2020)
●American Society for Radiation Oncology (ASTRO): Guideline on the role of postoperative radiation therapy for endometrial cancer (2014, reaffirmed 2017)
●SGO: Recommendations for post-treatment surveillance and diagnosis of recurrence in women with gynecologic malignancies, update (2017)
●American Brachytherapy Society (ABS): Consensus statement for brachytherapy for the treatment of medically inoperable endometrial cancer (2015)
●ACOG and SGO: Practice bulletin on endometrial cancer (2015)
●American Society of Clinical Oncology (ASCO): Clinical practice guideline endorsement of the ASTRO evidence-based guideline for postoperative radiation therapy for endometrial cancer (2015)
●SGO: Clinical practice statement − The role of sentinel lymph node mapping in endometrial cancer (2015)
●ACOG and SGO: Practice bulletin on Lynch syndrome (2014)
●Choosing Wisely: Don't recommend radiation following hysterectomy for endometrial cancer patients with low-risk disease (2014)
●SGO: Clinical practice statement − Screening for Lynch syndrome in endometrial cancer (2014)
●Choosing Wisely: Don't perform pap tests for surveillance of women with a history of endometrial cancer (2013)
Europe
●European Society of Gynaecological Oncology (ESGO)/European SocieTy for Radiotherapy and Oncology (ESTRO)/European Society of Pathology (ESP): Guidelines for the management of patients with endometrial carcinoma (2021)
●European Society of Urogenital Radiology (ESUR): Endometrial cancer MRI staging – Updated guidelines (2019)
●European Society for Medical Oncology (ESMO)-ESGO-ESTRO: Consensus conference on endometrial cancer – Diagnosis, treatment, and follow-up (2016)
●ESMO: Endometrial cancer – Clinical practice guidelines for diagnosis, treatment, and follow-up (2013)
United Kingdom
●National Institute for Health and Care Excellence (NICE): Diagnostics guidelines on testing strategies for Lynch syndrome in people with endometrial cancer (2020)
●British Gynaecological Cancer Society (BGCS): Sentinel consensus document for vulval, endometrial, and cervical cancer (2019)
●Choosing Wisely UK: Royal College of Obstetricians and Gynaecologists (RCOG) − Endometrial hyperplasia can often be managed without surgery (2018)
●BGCS: Uterine cancer guidelines − Recommendations for practice (2017)
●Royal College of Obstetricians and Gynaecologists (RCOG)/British Society for Gynaecological Endoscopy (BSGE): Green-top guideline for management of endometrial hyperplasia (2016)
●NICE: Interventional procedures guidance on laparoscopic hysterectomy (including laparoscopic total hysterectomy and laparoscopically assisted vaginal hysterectomy) for endometrial cancer (2010)
Australia-New Zealand
●Cancer Australia: Follow-up care for women with low-risk endometrial cancer – A guide for general practitioners (2017)
●Cancer Council Australia (CCA): Clinical practice guidelines for the treatment and management of endometrial cancer (2014)
Japan
●[In Japanese] Japan Society of Gynecologic Oncology (JSGO): Endometrial cancer treatment guidelines (2018)
